AG
GOSS icon

Algert Global’s Gossamer Bio GOSS Stock Holding History

Algert Global’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,154
Closed -$1.03M – 1231
2025
Q4 		$1.03M Buy
+4,154
New +$948K 0.02% 841
2024
Q4 		– Sell
-1,488
Closed -$117K – 1230
2024
Q3 		$117K Buy
1,488
+444
+43% +$34.2K ﹤0.01% 1101
2024
Q2 		$75.3K Buy
+1,044
New +$62.5K ﹤0.01% 1419
2022
Q4 		– Sell
-1,562
Closed -$1.5M – 1181
2022
Q3 		$1.5M Sell
1,562
-216
-12% -$214K 0.09% 384
2022
Q2 		$1.19M Buy
1,778
+716
+67% +$444K 0.09% 402
2022
Q1 		$737K Buy
+1,062
New +$819K 0.05% 657

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Algert Global's GOSS Position: Q1 2026 in Review

Algert Global sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 4,154 shares — an estimated $1.03M sold.

Algert Global first reported a position in GOSS in Q1 2022 and held it in 6 quarters. The position peaked at $1.5M in Q3 2022. 181 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Algert Global reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Algert Global sold 4,154 Gossamer Bio shares in Q1 2026, an estimated $1.03M.
  • Algert Global first reported a position in Gossamer Bio in Q1 2022 and held it in 6 quarters.
  • Algert Global's Gossamer Bio position peaked at $1.5M in Q3 2022.
  • 181 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.